{"id":"two-week-course-of-radiation","safety":{"commonSideEffects":[{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Skin erythema/dermatitis"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Hair loss (alopecia)"},{"rate":null,"effect":"Mucositis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Radiation therapy delivers high-energy particles or photons that create double-strand breaks in DNA, triggering apoptosis in rapidly dividing cancer cells. A two-week course typically represents a hypofractionated or abbreviated regimen designed to balance efficacy with reduced treatment burden and toxicity compared to conventional multi-week protocols.","oneSentence":"Ionizing radiation damages cancer cell DNA to inhibit tumor growth and induce cell death.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:54:34.763Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Solid tumors (specific indication not specified in source)"}]},"trialDetails":[{"nctId":"NCT05825066","phase":"PHASE2","title":"Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-08-01","conditions":"Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma","enrollment":64},{"nctId":"NCT01011920","phase":"PHASE2","title":"Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2009-11","conditions":"Central Nervous System Lymphoma","enrollment":227},{"nctId":"NCT06333899","phase":"EARLY_PHASE1","title":"Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion","status":"RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2025-08-03","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma","enrollment":15},{"nctId":"NCT00581906","phase":"","title":"Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-02","conditions":"Head and Neck Cancer","enrollment":272},{"nctId":"NCT07447895","phase":"NA","title":"Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies","status":"NOT_YET_RECRUITING","sponsor":"University of Cincinnati","startDate":"2026-04-01","conditions":"Cervical Cancer, Radiation Therapy Complication, Pelvic Floor Disorders","enrollment":28},{"nctId":"NCT03483337","phase":"","title":"New MRI Biomarkers in Head and Neck Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-03-16","conditions":"Head and Neck Cancer, Thyroid Cancer","enrollment":200},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT07380230","phase":"NA","title":"Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"LI FENG","startDate":"2026-01-27","conditions":"Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer","enrollment":60},{"nctId":"NCT06312982","phase":"PHASE2, PHASE3","title":"A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-03-16","conditions":"Locally Advanced Rectal Carcinoma","enrollment":375},{"nctId":"NCT07281157","phase":"PHASE2","title":"Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-11-01","conditions":"Advanced Colorectal Cancer","enrollment":30},{"nctId":"NCT07297030","phase":"PHASE2","title":"SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-12-20","conditions":"Rectal Cancer","enrollment":37},{"nctId":"NCT06576973","phase":"PHASE2","title":"Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-08-08","conditions":"Esophageal Squamous Cell Carcinoma, Neoadjuvant Treatment","enrollment":35},{"nctId":"NCT05659251","phase":"PHASE2","title":"Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-12-01","conditions":"Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy","enrollment":48},{"nctId":"NCT07244978","phase":"PHASE2","title":"Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12-01","conditions":"Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy","enrollment":49},{"nctId":"NCT03532295","phase":"PHASE2","title":"Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-04-20","conditions":"Glioma, Glioblastoma","enrollment":51},{"nctId":"NCT06706401","phase":"PHASE3","title":"Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2025-02-20","conditions":"Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer","enrollment":460},{"nctId":"NCT07086469","phase":"PHASE2","title":"Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-07-20","conditions":"Toripalimab, Surufatinib, Neoadjuvant Immunochemotherapy","enrollment":69},{"nctId":"NCT01202851","phase":"PHASE3","title":"Relaxation for Women With Breast Cancer Undergoing Radiotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-02-10","conditions":"Breast Cancer","enrollment":681},{"nctId":"NCT05947045","phase":"NA","title":"Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2023-06-22","conditions":"Brain Tumor","enrollment":45},{"nctId":"NCT00107198","phase":"PHASE2","title":"Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2006-01-02","conditions":"Ann Arbor Stage I Childhood Hodgkin Lymphoma, Ann Arbor Stage II Childhood Hodgkin Lymphoma, Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma","enrollment":188},{"nctId":"NCT06470464","phase":"PHASE2","title":"Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor","status":"COMPLETED","sponsor":"Shandong First Medical University","startDate":"2021-11-11","conditions":"Germ Cell Tumor, Yolk Sac Tumor","enrollment":20},{"nctId":"NCT07161115","phase":"PHASE2","title":"Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Longhao Li","startDate":"2025-09-19","conditions":"Rectal Adenocarcinoma","enrollment":60},{"nctId":"NCT00186888","phase":"PHASE3","title":"Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2005-04-07","conditions":"Retinoblastoma, Retinal Neoplasm","enrollment":107},{"nctId":"NCT05816785","phase":"EARLY_PHASE1","title":"Pilot Study of Imatinib Cetuximab Combo for H & N Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-04-18","conditions":"Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck","enrollment":15},{"nctId":"NCT07070076","phase":"NA","title":"A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Li Qiang","startDate":"2026-08-01","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":286},{"nctId":"NCT07142200","phase":"PHASE2","title":"A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-09-01","conditions":"Bladder (Urothelial, Transitional Cell) Cancer","enrollment":45},{"nctId":"NCT07137858","phase":"PHASE2","title":"Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-15","conditions":"Oral Squamous Cell Carcinoma (OSCC), Neoadjuvant Chemoimmunotherapy","enrollment":70},{"nctId":"NCT07118800","phase":"PHASE3","title":"Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old","status":"NOT_YET_RECRUITING","sponsor":"UNICANCER","startDate":"2025-12-15","conditions":"Locally Advanced Rectal Adenocarcinoma","enrollment":160},{"nctId":"NCT02846389","phase":"NA","title":"Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer","status":"TERMINATED","sponsor":"Hackensack Meridian Health","startDate":"2016-06-21","conditions":"Cancer Related Fatigue","enrollment":24},{"nctId":"NCT07052669","phase":"PHASE3","title":"Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-07-01","conditions":"Locally Advanced Non-Small Cell Lung Cancer","enrollment":311},{"nctId":"NCT06850090","phase":"PHASE3","title":"Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial","status":"NOT_YET_RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2025-07-30","conditions":"Rectal Cancer, Rectal Cancer Patients","enrollment":210},{"nctId":"NCT04021108","phase":"PHASE2","title":"Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2019-07-22","conditions":"Gastroesophageal Adenocarcinoma","enrollment":80},{"nctId":"NCT05161572","phase":"PHASE2","title":"Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer","status":"TERMINATED","sponsor":"Fudan University","startDate":"2021-09-28","conditions":"Stomach Neoplasms, Esophagogastric Junction Disorder, Neoadjuvant Therapy","enrollment":6},{"nctId":"NCT07020247","phase":"PHASE3","title":"Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2024-11-19","conditions":"Locally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy","enrollment":184},{"nctId":"NCT05253846","phase":"PHASE2","title":"Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2022-01-25","conditions":"Locally Advanced Rectal Cancer","enrollment":63},{"nctId":"NCT06998342","phase":"PHASE2","title":"MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Vermont Medical Center","startDate":"2025-06","conditions":"Cutaneous Squamous Cell Carcinoma (CSCC)","enrollment":24},{"nctId":"NCT05704985","phase":"PHASE1","title":"Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"DEKA Biosciences","startDate":"2023-04-03","conditions":"Cancer, Solid Tumor, Colorectal Cancer","enrollment":39},{"nctId":"NCT04456322","phase":"PHASE3","title":"Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-08-17","conditions":"Nasopharyngeal Carcinoma","enrollment":381},{"nctId":"NCT06861712","phase":"PHASE2","title":"Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-05-06","conditions":"Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Stereotactic Body Radiation Therapy (SBRT)","enrollment":50},{"nctId":"NCT06911684","phase":"PHASE2","title":"Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-04-30","conditions":"Rectal Cancer Patients","enrollment":88},{"nctId":"NCT06931808","phase":"PHASE4","title":"Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-03-01","conditions":"Localized Advanced Rectal Adenocarcinoma","enrollment":20},{"nctId":"NCT05216653","phase":"PHASE2","title":"Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)","status":"COMPLETED","sponsor":"Sir Run Run Shaw Hospital","startDate":"2022-04-07","conditions":"MSS Locally Advanced Rectal Adenocarcinoma","enrollment":32},{"nctId":"NCT06869239","phase":"","title":"Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy","status":"RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2025-02-25","conditions":"Limited-stage Small Cell Lung Cancer (LS-SCLC)","enrollment":65},{"nctId":"NCT04460352","phase":"PHASE3","title":"Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer","status":"RECRUITING","sponsor":"Karolinska University Hospital","startDate":"2020-11-27","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":1020},{"nctId":"NCT04223024","phase":"PHASE2","title":"Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-01-31","conditions":"Nasopharyngeal Carcinoma","enrollment":246},{"nctId":"NCT06835179","phase":"PHASE2","title":"SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-02","conditions":"Unresectable Metastatic Colorectal Cancer, Microsatellite Stable (MSS) Colorectal Cancer (CRC), RAS-mutant Colorectal Cancer","enrollment":28},{"nctId":"NCT03443128","phase":"PHASE2","title":"Vinorelbine for Recurrent ALCL-2017","status":"COMPLETED","sponsor":"Children's Cancer Group, China","startDate":"2016-11","conditions":"Anaplastic Large Cell Lymphoma, Vinorelbine","enrollment":20},{"nctId":"NCT06069115","phase":"","title":"Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort","status":"RECRUITING","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2023-07-18","conditions":"Breast Neoplasms, Radiation Pneumonia, Radiation Pneumonitis","enrollment":200},{"nctId":"NCT03495960","phase":"PHASE2","title":"Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2019-06-15","conditions":"Primary Central Nervous System Lymphoma","enrollment":72},{"nctId":"NCT06353061","phase":"PHASE2","title":"Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-04-15","conditions":"Cervical Cancer, Radiotherapy, Metformin","enrollment":51},{"nctId":"NCT06751901","phase":"PHASE2","title":"Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2024-03-11","conditions":"Advanced NSCLC","enrollment":10},{"nctId":"NCT06752057","phase":"NA","title":"Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2024-09-01","conditions":"Advanced NSCLC","enrollment":10},{"nctId":"NCT06751849","phase":"PHASE2","title":"Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2024-03-11","conditions":"Advanced NSCLC","enrollment":10},{"nctId":"NCT06752044","phase":"NA","title":"Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2024-09-01","conditions":"Advanced NSCLC","enrollment":10},{"nctId":"NCT06725836","phase":"NA","title":"Clinical Testing of Invasive Spinal Cord Stimulation and Evaluation of Its Physiological Effects Using the Electroencephalography","status":"RECRUITING","sponsor":"Artur Biktimirov","startDate":"2023-04-22","conditions":"Spinal Cord Injuries (SCI), Spinal Cord Injury","enrollment":35},{"nctId":"NCT06330545","phase":"NA","title":"Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2024-09-16","conditions":"Dupuytren Contracture","enrollment":95},{"nctId":"NCT03515538","phase":"PHASE2","title":"Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers","status":"COMPLETED","sponsor":"EpicentRx, Inc.","startDate":"2018-07-12","conditions":"Oral Mucositis","enrollment":53},{"nctId":"NCT01811992","phase":"PHASE1","title":"Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2014-04","conditions":"Malignant Glioma, Glioblastoma Multiforme","enrollment":19},{"nctId":"NCT06595641","phase":"NA","title":"Effect of Transfer Energy Capacitive Resistive Therapy on Shoulder Pain and Function in Shoulder Impingement Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Impingement Syndrome, Shoulder","enrollment":30},{"nctId":"NCT06591078","phase":"NA","title":"Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer","status":"NOT_YET_RECRUITING","sponsor":"Ying Zhang","startDate":"2024-09-15","conditions":"Cervical Cancer","enrollment":90},{"nctId":"NCT03878485","phase":"NA","title":"Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-11-06","conditions":"Oligometastases of the Spine","enrollment":10},{"nctId":"NCT03481114","phase":"PHASE2","title":"Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2017-08-28","conditions":"Non-small Cell Lung Cancer","enrollment":56},{"nctId":"NCT06406556","phase":"PHASE2","title":"Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2016-03-01","conditions":"Extranodal NK/T-cell Lymphoma","enrollment":90},{"nctId":"NCT06396481","phase":"EARLY_PHASE1","title":"Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-04-30","conditions":"GBM, DIPG Brain Tumor, Medulloblastoma","enrollment":25},{"nctId":"NCT05905315","phase":"PHASE2","title":"Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2024-01-01","conditions":"Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva","enrollment":98},{"nctId":"NCT02782715","phase":"PHASE1, PHASE2","title":"Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2018-06-28","conditions":"Carcinoma, Renal Cell","enrollment":3},{"nctId":"NCT06313450","phase":"NA","title":"De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-03-04","conditions":"Nasopharyngeal Carcinoma, Radiotherapy; Complications, IMMUNOTHERAPY","enrollment":112},{"nctId":"NCT06261125","phase":"PHASE2","title":"Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)","status":"RECRUITING","sponsor":"Mian XI","startDate":"2024-03-10","conditions":"Hepatocellular Carcinoma","enrollment":60},{"nctId":"NCT02128100","phase":"PHASE2","title":"Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2014-09-19","conditions":"Pancreatic Cancer Non-resectable","enrollment":5},{"nctId":"NCT06195670","phase":"PHASE1, PHASE2","title":"Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-01","conditions":"CRC, Metastatic Colorectal Cancer, Metastatic Colorectal Adenocarcinoma","enrollment":220},{"nctId":"NCT04238728","phase":"PHASE1","title":"Silverlon to Reduce Radiation Dermatitis","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2020-08-31","conditions":"Radiation Dermatitis","enrollment":31},{"nctId":"NCT03399552","phase":"PHASE1, PHASE2","title":"Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-12-20","conditions":"Malignant Mesothelioma (MPM)","enrollment":15},{"nctId":"NCT02551237","phase":"PHASE3","title":"Neoadjuvant Treatment for Advanced Rectal Carcinoma","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2016-01-07","conditions":"Rectal Carcinoma","enrollment":103},{"nctId":"NCT05165056","phase":"NA","title":"Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity","status":"RECRUITING","sponsor":"Jessa Hospital","startDate":"2022-08-24","conditions":"Radiotherapy Side Effect, Vaginal Abnormality","enrollment":62},{"nctId":"NCT00499083","phase":"PHASE2","title":"Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2006-05-01","conditions":"Breast Cancer","enrollment":17},{"nctId":"NCT00614172","phase":"NA","title":"Proton Therapy for Early Stage Breast Cancer","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2004-02","conditions":"Early-Stage Breast Cancer","enrollment":50},{"nctId":"NCT04988750","phase":"NA","title":"Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients","status":"UNKNOWN","sponsor":"NaviFUS Corporation","startDate":"2021-09-23","conditions":"Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT06024356","phase":"","title":"Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2023-09-20","conditions":"Colorectal Neoplasms","enrollment":26},{"nctId":"NCT00638612","phase":"PHASE1","title":"AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2008-08","conditions":"Pancreatic Adenocarcinoma, Pancreatic Cancer","enrollment":27},{"nctId":"NCT00482677","phase":"PHASE3","title":"Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2007-11-14","conditions":"Brain and Central Nervous System Tumors","enrollment":562},{"nctId":"NCT01713439","phase":"PHASE1","title":"Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"1997-12","conditions":"Neuroblastoma","enrollment":32},{"nctId":"NCT00003298","phase":"PHASE2","title":"Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer","status":"COMPLETED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"1999-06-01","conditions":"Gastric Cancer","enrollment":39},{"nctId":"NCT05868317","phase":"PHASE2","title":"Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer","status":"UNKNOWN","sponsor":"Salah Azaïz Cancer Institute","startDate":"2020-11-01","conditions":"Rectal Cancer, Locally Advanced","enrollment":70},{"nctId":"NCT05858567","phase":"PHASE2","title":"Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2023-05-11","conditions":"Rectal Cancer","enrollment":30},{"nctId":"NCT05807165","phase":"","title":"HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-08-01","conditions":"Brain Oligometastases","enrollment":115},{"nctId":"NCT05794750","phase":"PHASE2","title":"Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）","status":"NOT_YET_RECRUITING","sponsor":"JIN JING","startDate":"2023-04-24","conditions":"Locally Advanced Rectal Cancer","enrollment":50},{"nctId":"NCT05673343","phase":"","title":"The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-04","conditions":"the Prognostic Value of Pre-treatment NLR in Patients With Locally Advenced Rectal Cancer and Post-treatment","enrollment":100},{"nctId":"NCT05279612","phase":"","title":"Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Surgery in Laparoscope for Advanced Colon Cancer","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2021-10-01","conditions":"Colon Neoplasm","enrollment":177},{"nctId":"NCT05561699","phase":"NA","title":"Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-09-28","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":66},{"nctId":"NCT05469672","phase":"NA","title":"The Effect of Laser Therapy in the Management of Adhesive Capsulitis: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Necmettin Erbakan University","startDate":"2022-09-25","conditions":"Pain Disorder, Low Level Laser Therapy","enrollment":40},{"nctId":"NCT04389086","phase":"PHASE3","title":"Induction Chemotherapy for Locally Recurrent Rectal Cancer","status":"RECRUITING","sponsor":"Catharina Ziekenhuis Eindhoven","startDate":"2020-11-13","conditions":"Recurrent Rectal Cancer","enrollment":364},{"nctId":"NCT01516593","phase":"PHASE2","title":"Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma","status":"COMPLETED","sponsor":"Andres J. M. Ferreri","startDate":"2011-11","conditions":"HIV, Burkitt's Lymphoma","enrollment":19},{"nctId":"NCT05424432","phase":"PHASE2","title":"Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus","status":"UNKNOWN","sponsor":"Jiangsu Cancer Institute & Hospital","startDate":"2022-04-29","conditions":"Locally Advanced Esophageal Carcinoma","enrollment":63},{"nctId":"NCT04650659","phase":"","title":"Functional Exercise Tests in Patients With Systemic Sclerosis","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2021-07-27","conditions":"Scleroderma, Systemic, Lung Diseases, Interstitial, Pulmonary Arterial Hypertension","enrollment":83},{"nctId":"NCT05292417","phase":"PHASE2","title":"Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2022-03-25","conditions":"Colorectal Neoplasms","enrollment":71},{"nctId":"NCT03823989","phase":"PHASE1","title":"Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients","status":"COMPLETED","sponsor":"Lipomedix Pharmaceuticals Inc.","startDate":"2019-01-03","conditions":"Cancer, Solid Tumor, Metastatic Disease","enrollment":18},{"nctId":"NCT04418895","phase":"PHASE2","title":"Neoadjuvant Therapy for Localized Rectal Adenocarcinoma","status":"WITHDRAWN","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2021-08-13","conditions":"Rectal Adenocarcinoma","enrollment":""},{"nctId":"NCT04607642","phase":"PHASE2","title":"Trial of BMX-001 or Placebo in Head and Neck Cancer Patients","status":"WITHDRAWN","sponsor":"BioMimetix JV, LLC","startDate":"2021-07","conditions":"Head and Neck Cancer","enrollment":""},{"nctId":"NCT03484221","phase":"PHASE2","title":"Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"China Medical University, China","startDate":"2018-04-01","conditions":"Rectal Neoplasms, Drug Therapy, Radiation","enrollment":30},{"nctId":"NCT03044626","phase":"PHASE2","title":"Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC","status":"COMPLETED","sponsor":"AIO-Studien-gGmbH","startDate":"2017-02-10","conditions":"Carcinoma，Non-Small-Cell Lung, Metastatic Lung Cancer, Nonsmall Cell Lung Cancer","enrollment":101}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["experimental arm"],"phase":"phase_3","status":"active","brandName":"Two-week course of radiation","genericName":"Two-week course of radiation","companyName":"Jong Hoon Lee","companyId":"jong-hoon-lee","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ionizing radiation damages cancer cell DNA to inhibit tumor growth and induce cell death. Used for Solid tumors (specific indication not specified in source).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}